- mmahomed2
Phase II SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases
Valitor has been awarded a Phase II SBIR grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This project will enable us to refine an IND-candidate for our lead compound, as well as to identify additional related applications for our multivalent protein conjugation technology.